PRMT5 is a Poor Prognostic Marker for NSCLC and Inhibition of PRMT5 Results in Increased Lung Cancer Sensitivity to Cisplatin and Radiotherapy

被引：0
|
作者：
Welliver, Meng [1 ]
Jin, Feng [2 ]
Otterson, Gregory [1 ]
Carbone, David [3 ]
机构：
[1] Ohio State Univ Ccc, Radiat Oncol, Columbus, OH USA
[2] Ohio State Univ, Radiat Oncol, Columbus, OH 43210 USA
[3] Ohio State Univ Ccc, Internal Med, Columbus, OH USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
D O I：
10.1016/j.jtho.2016.11.1144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-092
引用
收藏
页码：S844 / S844
页数：1
相关论文
共 50 条
  • [41] Tricyclic Carboxamide Derivatives as PRMT5 Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2022,
  • [42] Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatment
    Desert, Romain
    Goyal, Lipika
    Baumert, Thomas F.
    GUT, 2024,
  • [43] PRMT5 inhibition as a therapeutic strategy for KRAS mutant CRC: downstream mediators of the PRMT5-KRAS crosstalk
    Shifteh, David
    Sapir, Tzuriel
    Pahmer, Moshe
    Goel, Sanjay
    Maitra, Radhashree
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Inhibition of PRMT5 is Synthetic Lethal in Mesotheliomas Harboring MTAP Loss
    Sharkey, Annabel
    Martinson, Luke
    Le Quesne, John
    Moore, David
    Nakas, Apostolos
    Quirke, Phillip
    Taylor, Morag
    Tenconi, Sara
    Wilson, Gareth
    Waller, David
    Swanton, Charles
    Busacca, Sara
    Fennell, Dean
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1346 - S1346
  • [45] PRMT5促进NSCLC细胞增殖、生长的实验研究
    景鹏宇
    朱喜明
    赵楠
    谷仲平
    临床医学研究与实践, 2022, 7 (16) : 1 - 3
  • [46] PRMT5 Promotes EMT Through Regulating Akt Activity in Human Lung Cancer
    Huang, Jianhao
    Zheng, Yonghua
    Zheng, Xiao
    Qian, Bao
    Yin, Qi
    Lu, Jingjing
    Lei, Han
    CELL TRANSPLANTATION, 2021, 30
  • [47] LKB1 regulates PRMT5 activity in breast cancer
    Lattouf, Hanine
    Kassem, Loay
    Jacquemetton, Julien
    Choucair, Ali
    Poulard, Coralie
    Tredan, Olivier
    Corbo, Laura
    Diab-Assaf, Mona
    Hussein, Nader
    Treilleux, Isabelle
    Le Romancer, Muriel
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (03) : 595 - 606
  • [48] High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer
    Tan, Lei
    Xiao, Kanghua
    Ye, Yunlin
    Liang, Haitao
    Chen, Mingkun
    Luo, Junhang
    Qin, Zike
    AGING-US, 2020, 12 (09): : 8728 - 8741
  • [49] PRMT5 Inhibition Promotes PD-L1 Expression and Immuno-Resistance in Lung Cancer
    Hu, Rui
    Zhou, Bingqian
    Chen, Zheyi
    Chen, Shiyu
    Chen, Ningdai
    Shen, Lisong
    Xiao, Haibo
    Zheng, Yingxia
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [50] A complex signature network that controls the upregulation of PRMT5 in colorectal cancer
    Wei, Han
    Hartley, Antja-Voy
    Motolani, Aishat
    Jiang, Guanglong
    Safa, Ahmad
    Prabhu, Lakshmi
    Liu, Yunlong
    Lu, Tao
    GENES & DISEASES, 2022, 9 (02) : 285 - 287
12345